HomeSearchMetabolic Brain Disease

Metabolic Brain Disease

Springer · United States · Est. 1986

ISSN1573-7365
SJR Q2WOS SCIEScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.995
H-Indexi
99
SNIPi
0.856
Total Worksi
3,477
Total Citationsi
82,486
2yr Mean Citednessi
3.11
Open Impact Factor alternative
Retractions
7
Source: Retraction Watch

Aims & Scope

Metabolic Brain Disease is a forum for publishing high-quality basic and clinical papers on a broad range of brain disorders in human and animal studies. Topics include stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral and more. The journal serves neuroscientists, psychiatrists, neurologists, pathologists, and others involved in research and treatment of brain disorders. We will consider research papers, short communications, review articles and editorials.

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published1986
Annual Volume~ 204 articles / year
StatusActive (last: 2026)
Total Publications3,477
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/11 · 55%
Do you know the journal / publisher?
Springer
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1573-7365
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
162
4.2k
2019
121
3k
2020
225
4.8k
2021
272
4k
2022
184
2k
2023
162
1.2k
2024
267
1.2k
2025
185
74
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

BiochemistryQ2
Cellular and Molecular NeuroscienceQ2
Neurology (clinical)Q2

Subject Classification

Web of Science Categories

Endocrinology & MetabolismNeurosciences

Scopus Categories

Neurology (clinical)BiochemistryCellular and Molecular Neuroscience

Research Topics (OpenAlex)

Neuroscience and Neuropharmacology ResearchLiver Disease and TransplantationMetabolism and Genetic DisordersNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersAlzheimer's disease research and treatmentsMitochondrial Function and PathologyLiver Disease Diagnosis and TreatmentDiet and metabolism studiesStress Responses and Cortisol

Frequently asked questions about Metabolic Brain Disease

Is Metabolic Brain Disease a predatory journal?

PubScope has no integrity flags on record for Metabolic Brain Disease: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Metabolic Brain Disease?

Metabolic Brain Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.11.

Is Metabolic Brain Disease indexed in Scopus and Web of Science?

Metabolic Brain Disease is indexed in Web of Science, Scopus.

What is the aims and scope of Metabolic Brain Disease?

Metabolic Brain Disease is a forum for publishing high-quality basic and clinical papers on a broad range of brain disorders in human and animal studies. Topics include stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral and more. The journal serves neuroscientists, psychiatrist

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref